TickerFactsScreenerDevelopers

Viridian Therapeutics, Inc.\DE (VRDN) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$197.0K2014: -$6.87M2015: -$11.19M2016: -$16.99M2017: -$26.53M2018: -$33.08M2019: -$41.98M2020: -$110.38M2021: -$79.73M2022: -$134.30M2023: -$254.45M2024: -$299.04M2025: -$363.39M-$363.39M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$363.39M-21.5%
2024-$299.04M-17.5%
2023-$254.45M-89.5%
2022-$134.30M-68.5%
2021-$79.73M+27.8%
2020-$110.38M-162.9%
2019-$41.98M-26.9%
2018-$33.08M-24.7%
2017-$26.53M-56.2%
2016-$16.99M-51.8%
2015-$11.19M-62.9%
2014-$6.87M-3385.8%
2013-$197.0K—